BSE filing, NSE: INTELLADV. Summary written from the filing by ALFA Finder's alert engine.
Caspian Corporate Services Ltd: key numbers
- Share price
- ₹34.02
- Market cap
- ₹43.07 Cr
- Revenue (annual)
- ₹102.1 Cr
- Net profit (annual)
- ₹0.04 Cr
- P/E (TTM)
- -13.2×Sector 19.7×
- Promoter holding
- 70.92%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Caspian Corporate Services Ltd
All →Caspian Corporate Services Board Meeting Date
Caspian Corporate Services will hold a board meeting on 6 November 2026 to consider quarterly and half-year results and reconstitute committees. The filing is an advance notice; no decision has been taken yet.
Caspian Corporate Services Other Announcement
Caspian Corporate Services filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold about 71% of equity.
Caspian Corporate Services Other Announcement
Caspian Corporate Services has submitted its quarterly shareholding pattern under Regulation 31(1)(b). This routine filing provides disclosure of the company's equity ownership structure.
Caspian Corporate Services Management Change
Caspian Corporate Services Ltd announced the re-appointment of its Statutory Auditor and MD, and a change in designation for one of its Independent Directors.
Caspian Corporate Services Dividend
Caspian Corporate Services has fixed Friday, October 9, 2026, as the record date for its final dividend of Rs. 0.50 per equity share.
Caspian Corporate Services Annual General Meeting
Caspian Corporate Services held its 15th AGM on September 28, 2026, discussing ordinary and special business items, including dividend declaration and managerial remuneration approvals.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.